OPHI MEXC RealStocks
Own real OPHI shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-18 19:47:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
CollPlant Biotechnologies Ltd (OPHI) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $3.49, with a market capitalization of $10.09M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.09 to $4.28. This page covers its latest market performance, valuation, price trends and company information.
$10.09M | |
$3.67 | |
$3.70 | |
$3.27 | |
$3.60 | |
25.52K | |
158.74K | |
-- | |
$4.28 | |
$3.09 | |
-- | |
2026-06-30 |
CollPlant Biotechnologies Ltd (OPHI) is currently trading at $3.49 as of 2026-11-18 19:44:00, down 5.42% ($0.20) from the previous close of $3.60
During today's regular trading session, OPHI has traded between $3.27 and $3.70, with a trading volume of 25.52K shares. The current price is near the middle of today's range.
Over the past seven days, CollPlant Biotechnologies Ltd (OPHI) moved from $3.65 to $3.49, representing a decline of 4.38% ($0.16).
The stock traded between $3.09 and $4.28 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 158.74 thousand shares, -- versus the previous seven-day period, indicating -- trading activity.
Position in Range: 33.6%
OPHI is currently trading at $3.49, placing it 33.6% of the way from its 52-week low of $3.09 to its 52-week high of $4.28. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
| Employees | 39 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of CollPlant Biotechnologies Ltd (OPHI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to OPHI, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between OPHI shares and USD.
OPHI Shares to USD
1.00 OPHI shares = 3.49 USD
Calculations are estimates based on the latest available price and are for reference only.